StockWatch
·
RHI MAGNESITA INDIA · Q2 FY27 · PREVIEW

Margins and momentum: can Q2 extend the profit surge?

After 83% net profit growth in Q1, the Street watches whether refractories demand holds and EBITDA stays on the 13% full-year guidance. A new MD, large institutional inflows, and a depressed stock valuation frame a quarter where execution on pricing will matter more than volume.

Q2 FY27 resultsRHIMRhi Magnesita India Ltd10 Nov 2026 · 3 min read

What to expect: revenue steady, margins the key metric

RHI Magnesita's Q2 narrative hinges on whether EBITDA margin holds near 13% — the company's full-year guidance. In Q1 FY27, the company reported ₹1,014 Cr revenue (+5.6% YoY) and net profit of ₹64.6 Cr (+83% YoY), with EBITDA margin at 14.5%, 3.7 percentage points above prior year. For Q2, on-plan expectations are revenue in the ₹1,000–₹1,100 Cr range (modest single-digit growth), with the critical watch: can margins stay elevated, or do they normalize toward the 13% guidance?

Expected revenue (Q2 FY27)

~₹1,050 Cr

Q1 was ₹1,014 Cr; flat-to-modest growth on-plan

Target EBITDA margin

13.0%–13.5%

Management guidance post-Q1; Q1 delivered 14.5% (above guidance)

Net profit expectation

₹55–65 Cr

Q1 was ₹64.6 Cr; steady-state assumes no margin surprise

Full-year FY27 revenue guide

₹4.69k Cr

Analyst consensus; +16.6% YoY. Q1+Q2 tracking at ~₹2,064 Cr YTD

A strong print means revenue at or above ₹1,100 Cr with EBITDA margin at 14%+, signaling durable pricing power in refractories despite modest volume growth. A weak print is revenue below ₹950 Cr or margin compression below 12.5%, which would raise questions about demand softness or competitive pricing pressure and force a rethink of the full-year guidance.

On track: FY27 guidance and the trajectory

RHI Magnesita is tracking well to its full-year targets. Analyst consensus projects ₹4.69k Cr revenue for FY27 (+16.6% YoY) and EPS of ₹14.60 (+74% YoY). Q1 delivered 5.6% revenue growth and 83% net profit growth — the profit surge came primarily from margin expansion, not volume. If Q2 maintains the 13%+ EBITDA margin, the company will be on track for 15%–16% full-year margin, well above historical averages, assuming volumes stay steady. The key risk: if margins compress in Q2 back to 12–12.5%, it suggests the Q1 margin beat was cyclical rather than structural.

What the Street says

Since last quarter: governance shifts and institutional repositioning

Recent developments
  • 1 · New MD and auditor in place

    Pankaj Malhan (DIN 08516185) appointed MD & CEO (approved at AGM on Sep 29, 2026), replacing prior leadership. BSR & Co. LLP appointed as statutory auditor, replacing PwC. Both transitions are routine but mark the start of a new chapter — watch for strategic commentary in Q2 earnings call.

  • 2 · Institutional ownership reshuffled

    SBI Mutual Fund acquired 8.09% stake (16.72M shares at ₹360 in Sep 2026), replacing the exit of Dalmia Bharat Refractories (which sold its entire 13.08% stake). FII ownership slipped from 5.0% to 3.98% YoY, while DII rose to 14.35%. The large MF entry signals confidence in the recovery narrative.

  • 3 · Subsidiary merger completed

    Intermetal Engineers (India) subsidiary merged with Ashwath Technologies effective Aug 18, 2026. No material impact expected, but indicates housekeeping efforts. No pledges or regulatory flags reported.

The setup: what to watch on result day (Nov 13)

RHI Magnesita reports Q2 FY27 on November 13, 2026. The result will be dissected on three fronts: 1. Margin hold: Does EBITDA margin stay above 13% (in line with guidance), or does it slip? This is the swing factor — a margin beat repeats the Q1 momentum, a miss invites guidance review. 2. Volume and pricing balance: Revenue growth modest (5–10% expected), but pricing power will show in gross margin trend. Q2 typically sees seasonal demand from steel / cement sectors — watch commentary on order book and pricing realizations. 3. FY27 guidance reaffirm: Management is expected to reaffirm ₹4.69k Cr FY27 revenue and 13% margin guidance. Any tweak would signal a demand or competitive shift. New MD's tone on strategy and capital allocation will also be closely read.

RHI Magnesita India enters Q2 FY27 from a position of strength: 83% profit growth in Q1, margin expansion to 14.5%, analyst consensus at 100% Buy, and a new, credible management team. Yet the stock trades near 10-year lows and 60% off ATH, implying heavy skepticism on durability. The Street sees 45–55% upside if the company can prove margins are structural, not cyclical. Q2 is the test: if EBITDA margin holds at 13%+ and the company keeps guidance, the 44–55% bull thesis stands. A margin miss or guidance cut would punish both near-term and full-year sentiment. The Nov 13 result will be the moment the market reprices this recovery narrative.

Informational and educational content only. Not investment advice.